Bank of America Corp
Change company Symbol lookup
Select an option...
BAC Bank of America Corp
FSLR First Solar Inc
MCVT Mill City Ventures III Ltd
EVRG Evergy Inc
TTWO Take-Two Interactive Software Inc
CLVS Clovis Oncology Inc
VNCE Vince Holding Corp
CREE Cree Inc
NDSN Nordson Corp
CIEN Ciena Corp
Go

Financials : Banks | Large Cap ValueCompany profile

Bank of America Corporation is a bank holding company and a financial holding company. The Company is a financial institution, serving individual consumers and others with a range of banking, investing, asset management and other financial and risk management products and services. The Company, through its banking and various non-bank subsidiaries, throughout the United States and in international markets, provides a range of banking and non-bank financial services and products through four business segments: Consumer Banking, which comprises Deposits and Consumer Lending; Global Wealth & Investment Management, which consists of two primary businesses: Merrill Lynch Global Wealth Management and U.S. Trust, Bank of America Private Wealth Management; Global Banking, which provides a range of lending-related products and services; Global Markets, which offers sales and trading services, and All Other, which consists of equity investments, residual expense allocations and other.

Premarket

Last Trade
Delayed
$24.05
-0.35 (-1.43%)
Bid
--
Ask
--
B/A Size
--

Market Hours

Closing Price
$24.40
Day's Change
0.00 (0.00%)
Bid
--
Ask
--
B/A Size
--
Day's High
--
Day's Low
--
Volume
(Light)
Volume:
344

10-day average volume:
85,611,568
344

New Research Coverage Highlights Omeros, Apple, Bio-Rad Laboratories, Cott, Darling Ingredients, and Osisko Gold Royalties -- Consolidated Revenues, Company Growth, and Expectations for 2018

8:25 am ET November 30, 2018 (Globe Newswire) Print

In new independent research reports released early this morning, Market Source Research released its latest key findings for all current investors, traders, and shareholders of Omeros Corporation (NASDAQ:OMER), Apple Inc. (NASDAQ:AAPL), Bio-Rad Laboratories, Inc. (NYSE:BIO), Cott Corporation (NYSE:COT), Darling Ingredients Inc. (NYSE:DAR), and Osisko Gold Royalties Ltd (NYSE:OR), including updated fundamental summaries, consolidated fiscal reporting, and fully-qualified certified analyst research.

Complimentary Access: Research Reports

Full copies of recently published reports are available to readers at the links below.

OMER DOWNLOAD: http://MarketSourceResearch.com/register/?so=OMER

AAPL DOWNLOAD: http://MarketSourceResearch.com/register/?so=AAPL

BIO DOWNLOAD: http://MarketSourceResearch.com/register/?so=BIO

COT DOWNLOAD: http://MarketSourceResearch.com/register/?so=COT

DAR DOWNLOAD: http://MarketSourceResearch.com/register/?so=DAR

OR DOWNLOAD: http://MarketSourceResearch.com/register/?so=OR

(You may have to copy and paste the link into your browser and hit the [ENTER] key)

The new research reports from Market Source Research, available for free download at the links above, examine Omeros Corporation (NASDAQ:OMER), Apple Inc. (NASDAQ:AAPL), Bio-Rad Laboratories, Inc. (NYSE:BIO), Cott Corporation (NYSE:COT), Darling Ingredients Inc. (NYSE:DAR), and Osisko Gold Royalties Ltd (NYSE:OR) on a fundamental level and outlines the overall demand for their products and services in addition to an in-depth review of the business strategy, management discussion, and overall direction going forward. Several excerpts from the recently released reports are available to today's readers below.

-----------------------------------------

Important Notice: the following excerpts are not designed to be standalone summaries and as such, important information may be missing from these samples. Please download the entire research report, free of charge, to ensure you are reading all relevant material information. All information in this release was accessed November 28th, 2018. Percentage calculations are performed after rounding. All amounts in millions (MM), except per share amounts.

-----------------------------------------

OMEROS CORPORATION (OMER) REPORT OVERVIEW

Omeros' Recent Financial Performance

For the three months ended September 30th, 2018 vs September 30th, 2017, Omeros reported revenue of $4.61MM vs $21.66MM (down 78.72%) and analysts estimated basic earnings per share -$0.81 vs -$0.16. For the twelve months ended December 31st, 2017 vs December 31st, 2016, Omeros reported revenue of $64.83MM vs $41.62MM (up 55.77%) and analysts estimated basic earnings per share -$1.17 vs -$1.65. Analysts expect earnings to be released on March 7th, 2019. The report will be for the fiscal period ending December 31st, 2018. The reported EPS for the same quarter last year was -$0.25. The estimated EPS forecast for the next fiscal year is -$1.13 and is expected to report on March 7th, 2019.

To read the full Omeros Corporation (OMER) report, download it here: http://MarketSourceResearch.com/register/?so=OMER

-----------------------------------------

APPLE INC. (AAPL) REPORT OVERVIEW

Apple's Recent Financial Performance

For the three months ended September 30th, 2018 vs September 30th, 2017, Apple reported revenue of $62,900.00MM vs $52,579.00MM (up 19.63%) and analysts estimated basic earnings per share $2.98 vs $2.10 (up 41.90%). For the twelve months ended September 30th, 2018 vs September 30th, 2017, Apple reported revenue of $265,595.00MM vs $229,234.00MM (up 15.86%) and analysts estimated basic earnings per share $12.01 vs $9.27 (up 29.56%). Analysts expect earnings to be released on February 7th, 2019. The report will be for the fiscal period ending December 31st, 2018. Based on 12 analysts' forecasts, the consensus EPS forecast for the quarter is $2.79. Reported EPS for the same quarter last year was $3.89. The estimated EPS forecast for the next fiscal year is $14.74 and is expected to report on November 7th, 2019.

To read the full Apple Inc. (AAPL) report, download it here: http://MarketSourceResearch.com/register/?so=AAPL

-----------------------------------------

BIO-RAD LABORATORIES, INC. (BIO) REPORT OVERVIEW

Bio-Rad Laboratories' Recent Financial Performance

For the three months ended September 30th, 2018 vs September 30th, 2017, Bio-Rad Laboratories reported revenue of $545.14MM vs $534.14MM (up 2.06%) and analysts estimated basic earnings per share $9.02 vs $0.74 (up 1,118.92%). For the twelve months ended December 31st, 2017 vs December 31st, 2016, Bio-Rad Laboratories reported revenue of $2,160.15MM vs $2,068.17MM (up 4.45%) and analysts estimated basic earnings per share $4.12 vs $0.88 (up 368.18%). Analysts expect earnings to be released on February 26th, 2019. The report will be for the fiscal period ending December 31st, 2018. Reported EPS for the same quarter last year was $1.50. The estimated EPS forecast for the next fiscal year is $6.79 and is expected to report on February 26th, 2019.

To read the full Bio-Rad Laboratories, Inc. (BIO) report, download it here: http://MarketSourceResearch.com/register/?so=BIO

-----------------------------------------

COTT CORPORATION (COT) REPORT OVERVIEW

Cott's Recent Financial Performance

For the three months ended September 30th, 2018 vs September 30th, 2017, Cott reported revenue of $609.30MM vs $580.90MM (up 4.89%) and basic earnings per share $0.07 vs $0.30 (down 76.67%). For the twelve months ended December 31st, 2017 vs December 31st, 2016, Cott reported revenue of $2,269.70MM vs $1,623.20MM (up 39.83%) and analysts estimated basic earnings per share -$0.01 vs -$0.61. Analysts expect earnings to be released on March 7th, 2019. The report will be for the fiscal period ending December 31st, 2018. The reported EPS for the same quarter last year was $0.02. The estimated EPS forecast for the next fiscal year is $0.36 and is expected to report on March 7th, 2019.

To read the full Cott Corporation (COT) report, download it here: http://MarketSourceResearch.com/register/?so=COT

-----------------------------------------

DARLING INGREDIENTS (DAR) REPORT OVERVIEW

Darling Ingredients' Recent Financial Performance

For the three months ended September 30th, 2018 vs September 30th, 2017, Darling Ingredients reported revenue of $812.58MM vs $936.26MM (down 13.21%) and analysts estimated basic earnings per share -$0.04 vs $0.05. For the twelve months ended December 31st, 2017 vs December 31st, 2016, Darling Ingredients reported revenue of $3,662.25MM vs $3,391.93MM (up 7.97%) and analysts estimated basic earnings per share $0.78 vs $0.62 (up 25.81%). Analysts expect earnings to be released on February 26th, 2019. The report will be for the fiscal period ending December 31st, 2018. The reported EPS for the same quarter last year was $0.10. The estimated EPS forecast for the next fiscal year is $1.05 and is expected to report on February 26th, 2019.

To read the full Darling Ingredients Inc. (DAR) report, download it here: http://MarketSourceResearch.com/register/?so=DAR

-----------------------------------------

OSISKO GOLD ROYALTIES LTD (OR) REPORT OVERVIEW

Osisko Gold Royalties' Recent Financial Performance

For the three months ended September 30th, 2018 vs September 30th, 2017, Osisko Gold Royalties reported revenue of $85.50MM vs $54.40MM (up 57.16%) and analysts estimated basic earnings per share $0.03 vs $0.04 (down 23.50%). For the twelve months ended December 31st, 2017 vs December 31st, 2016, Osisko Gold Royalties reported revenue of $164.47MM vs $47.33MM (up 247.48%) and analysts estimated basic earnings per share -$0.25 vs $0.30. Analysts expect earnings to be released on February 19th, 2019. The report will be for the fiscal period ending December 31st, 2018. The reported EPS for the same quarter last year was $0.01. The estimated EPS forecast for the next fiscal year is $0.11 and is expected to report on February 19th, 2019.

To read the full Osisko Gold Royalties Ltd (OR) report, download it here: http://MarketSourceResearch.com/register/?so=OR

-----------------------------------------

ABOUT MARKET SOURCE RESEARCH

Market Source Research delivers the key research reports that helps serious investors, registered brokers, professional traders, and personal investment advisers find reliable information in today's markets. Market Source Research's team is comprised of financial professionals, many of which hold Chartered Financial Analyst(R) (CFA(R)) designations and FINRA(R) BrokerCheck(R) certifications. Whether identifying emerging trends, or discovering new opportunity, the team at Market Source Research is dedicated to providing accurate, informative, and objective content that's ahead of the curve. With insights on individual companies as well as sectors, readers get the industry's best available combination of big-picture perspective as well as granular detail.

REGISTERED MEMBER STATUS

Market Source Research's oversight and audit staff are registered analysts, brokers, and/or financial advisers ("Registered Members") working within Equity Research, Media, and Compliance departments. Market Source Research's roster includes qualified CFA(R) charterholders, licensed securities attorneys, and registered FINRA(R) members holding duly issued CRD(R) numbers. Current licensed status of several Registered Members at Market Source Research have been independently verified by an outside audit firm, including policy and audit records duly executed by Registered Members. Complaints, concerns, questions, or inquiries regarding this release should be directed to Market Source Research's Compliance department by Phone, at +1 (704) 343-6361, or by E-mail at compliance@MarketSourceResearch.com.

LEGAL NOTICES

Information contained herein is not an offer or solicitation to buy, hold, or sell any security. Market Source Research, Market Source Research members, and/or Market Source Research affiliates are not responsible for any gains or losses that result from the opinions expressed. Market Source Research makes no representations as to the completeness, accuracy, or timeliness of the material provided and all materials are subject to change without notice. Market Source Research has not been compensated for the publication of this press release by any of the above mentioned companies. Market Source Research is not a financial advisory firm, investment adviser, or broker-dealer, and does not undertake any activities that would require such registration. For our full disclaimer, disclosure, and terms of service please visit our website.

Media Contact:

Hugo Moreau, Media Department

Office: +1 (704) 343-6361

E-mail: media@MarketSourceResearch.com

(C) 2018 Market Source Research. All Rights Reserved. For republishing permissions, please contact a partner network manager at partnership@MarketSourceResearch.com.

CFA(R) and Chartered Financial Analyst(R) are registered trademarks owned by CFA Institute.

FINRA(R), BrokerCheck(R), and CRD(R) are registered trademarks owned by Financial Industry Regulatory Authority, Inc.

Earnings Calendar and Events Data provided by |Terms of Use| © 2018 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

Information and news provided by ,, , Computrade Systems, Inc., , and

Copyright © 2018. All rights reserved.